Evaluation of the care of patients living with HIV/AIDS under antiretroviral treatment at the Matam Communal Medical Center in Conakry (2021-2023)

Résumé fourni par la source

Introduction: Biological and therapeutic monitoring of patients living with HIV (PLHIV) are important, particularly in areas where morbidity and mortality are high. Objective: To assess the current situation of care and the hematological profile of PLHIV on antiretroviral treatment at the Matam Communal Medical Center. Material and Methods: Two years’ prospective study, October 1st, 2021 to October 31st, 2023. Results: A total of 203 patients were studied. females were predominant (67.49%) with a sex ratio = 2.07. The majority of patients were in the 21-40 age group (44.82%), followed by 41-60 years (39.90%). The average age of the patients was 39 years with extremes of 18 and 76 years. Singles represented 65.02%, followed by divorced (19.21%) and married (15.27%). On the socio-professional level, housewives were the majority (33.49%), followed by workers (30.04%), and sales agents (23.64%). Amongst the 81 patients tested to their viral load, 70% had a detectable viral load. Immunodeficiency was generally advanced. The majority of patients had a LTCD4+ rate below 200Cells/µl. The mean LTCD4+ level was 124.52 cells/µl with a range of 5 to 349 cells/µl. Out of 203 PLHIV, 53% had a low hemoglobin level (mean 9.86g/dl). Out of 107 PLHIV/AIDS, the different types of anemia were observed: microcytic anemia (20.56%), normocytic anemia (79.43%), hypochromic anemia (30.84%), low hematocrit (71%), low leukocyte count (65.42%), low neutrophil count (40.18%), lymphocytes (60.74%), monocytes (54.20%), platelets (31.77%). Conclusion: Viral load and hematological profile of PLHIV/AIDS were determined to improve the management PLHIV, and to avoid antiviral therapeutic failures.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.